カテゴリ： MarketLine, イギリス, 企業調査

AstraZeneca PLC：企業の戦略・SWOT・財務情報

◆英語タイトル：AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4429
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：69
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AstraZeneca PLC – Strategy, SWOT and Corporate Finance Report
Summary

AstraZeneca PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AstraZeneca PLC (AstraZeneca or ‘the company’) is global biopharmaceutical company involved in developing, manufacturing and marketing prescription pharmaceuticals. The company provides drugs for three therapeutic areas including oncology, cardiovascular and metabolic disease (CVMD) and respiratory, while selectively pursuing therapies in autoimmunity, infection and neuroscience. The company has three strategic R&D centers located in Gaithersburg, the US; Gothenburg, Sweden; and Cambridge, the UK. Major brands of the company include Faslodex, Zoladex, Tagrisso, Iressa,Symbicort, Pulmicort, Lynparza, Nexium, and Onglyza. The company primarily operates across the Americas, Europe and Asia. AstraZeneca is headquartered in London, the UK.

Scope

- Detailed information on AstraZeneca PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis
- An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments
- Intelligence on AstraZeneca PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AstraZeneca PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AstraZeneca PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AstraZeneca PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
AstraZeneca PLC: Company Overview 9
AstraZeneca PLC: Overview and Key Facts 9
AstraZeneca PLC: Overview 9
AstraZeneca PLC: Key Facts 9
AstraZeneca PLC: Key Employees 11
AstraZeneca PLC: Key Employee Biographies 13
AstraZeneca PLC: Major Products and Services 19
AstraZeneca PLC: Company History 21
AstraZeneca PLC: Management Statement 31
AstraZeneca PLC: Locations and Subsidiaries 33
AstraZeneca PLC: Key Competitors 34
AstraZeneca PLC: Company Analysis 35
AstraZeneca PLC: Business Description 35
AstraZeneca PLC: SWOT Analysis 37
AstraZeneca PLC: SWOT Overview 37
AstraZeneca PLC: Strengths 37
AstraZeneca PLC: Weaknesses 39
AstraZeneca PLC: Opportunities 39
AstraZeneca PLC: Threats 41
AstraZeneca PLC: Corporate Financial Deals Activity 43
AstraZeneca PLC: Financial Deals Overview 43
AstraZeneca PLC: Targets and Partners 45
AstraZeneca PLC: Top Deals 2014 – 2018YTD* 50
AstraZeneca PLC: Advisors 51
AstraZeneca PLC: Top Financial Advisors 51
AstraZeneca PLC: Mergers and Acquisitions 52
AstraZeneca PLC: Corporate Venturing 53
AstraZeneca PLC: Capital Raising 54
AstraZeneca PLC: Partnership 55
AstraZeneca PLC: Divestments 56
AstraZeneca PLC: Recent Developments 57
AstraZeneca PLC: News and Events Summary 57
AstraZeneca PLC: Contracts 61
AstraZeneca PLC: Financial Deals 63
AstraZeneca PLC: Financial Performance 63
AstraZeneca PLC: Market Developments 63
AstraZeneca PLC: Regulatory and Legal Events 65
AstraZeneca PLC: Strategy and Operations 66
Appendix 67
Contact Us 67
Methodology 67
About MarketLine 68

List of Tables
Table 1: AstraZeneca PLC: Key Facts
Table 2: AstraZeneca PLC: Key Employees
Table 3: AstraZeneca PLC: Locations and Subsidiaries
Table 4: AstraZeneca PLC: Key Competitors
Table 5: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Table 7: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Table 9: AstraZeneca PLC: Targets and Partners
Table 10: AstraZeneca PLC: Top Deals 2014 - 2018YTD*
Table 11: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)
Table 12: AstraZeneca PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: AstraZeneca PLC: M&A Activity by Geography (2014 - YTD*2018)
Table 14: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: AstraZeneca PLC: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: AstraZeneca PLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: AstraZeneca PLC: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: AstraZeneca PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: AstraZeneca PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: AstraZeneca PLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: AstraZeneca PLC: Divestments by Geography (2014 - YTD*2018)
Table 22: AstraZeneca PLC: News and Events Summary
Table 23: AstraZeneca PLC: Contracts
Table 24: AstraZeneca PLC: Financial Deals
Table 25: AstraZeneca PLC: Financial Performance
Table 26: AstraZeneca PLC: Market Developments
Table 27: AstraZeneca PLC: Regulatory and Legal Events
Table 28: AstraZeneca PLC: Strategy and Operations

List of Figures
Figure 1: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Figure 3: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Figure 5: AstraZeneca PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: AstraZeneca PLC: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: AstraZeneca PLC: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: AstraZeneca PLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: AstraZeneca PLC: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: AstraZeneca PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: AstraZeneca PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: AstraZeneca PLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: AstraZeneca PLC: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[AstraZeneca PLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • LKQ Corporation：企業の戦略・SWOT・財務情報
    LKQ Corporation - Strategy, SWOT and Corporate Finance Report Summary LKQ Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hill International, Inc. (HIL)：企業の財務・戦略的SWOT分析
    Hill International, Inc. (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Colt Technology Services Group Ltd：企業の戦略的SWOT分析
    Colt Technology Services Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Prima BioMed Ltd (PRR)-製薬・医療分野：企業M&A・提携分析
    Summary Prima BioMed Ltd (Prima BioMed) is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company’s products are based on LAG-3 immune control mechanism which is active in the regulation of the T cell immune response. It deve …
  • National Jewish Health-製薬・医療分野：企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • CHC Group Ltd：企業の戦略的SWOT分析
    CHC Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Moser Baer India Ltd (MOSERBAER)：企業の財務・戦略的SWOT分析
    Moser Baer India Ltd (MOSERBAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kbc Bank Ireland Plc：企業の戦略・SWOT・財務分析
    Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report Summary Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Polynt SpA：企業の戦略的SWOT分析
    Polynt SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Advent Capital (Holdings) Ltd：企業の戦略・SWOT・財務情報
    Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • UK Mail Group Plc (UKM)：企業の財務・戦略的SWOT分析
    UK Mail Group Plc (UKM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Aushon BioSystems Inc：医療機器：M&Aディール及び事業提携情報
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that provides biomarker measurement and analysis products. The company offers biomarker therapeutic areas in microarray printing technology. It provides products such as ciraplex assay, cirascan imaging and cirasoft analysis and cir …
  • Milestone Scientific Inc (MLSS)：医療機器：M&Aディール及び事業提携情報
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields. The company’s medical specialties include anesthesiology, orthopedic surgery, pain medicine, …
  • Verge Genomics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Verge Genomics Inc (Verge Genomics) is a drug discovery company that focuses on the discovery of treatments for neurodegenerative diseases using human genomic data and machine learning. The company combines large-scale molecular, genomic and genetic data on multiple platforms and technologie …
  • Itamar Medical Ltd (ITMR)-医療機器分野：企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Eqtec plc (EQT)：電力：M&Aディール及び事業提携情報
    Summary Eqtec plc (Eqtec), formerly React Energy Plc, is a renewable energy company that develops, identifies, builds and operates renewable energy electricity and heat generation plants. The company carries out gasification technology used in industrial size power plants to convert waste into synth …
  • B.P. Marsh & Partners plc (BPM)：企業の財務・戦略的SWOT分析
    Summary B.P. Marsh & Partners plc (B.P. Marsh) is a financial service provider that offers venture capital and private equity investments. The company invests in early stage financial services intermediary businesses, including insurance intermediaries, financial advisors, wealth and fund managers a …
  • PROS Holdings Inc (PRO)：企業の財務・戦略的SWOT分析
    Summary PROS Holdings Inc (PROS) is an information technology company that offers profitability management and optimization software solutions. The company's products include Selling PRO, Pricing PRO, Revenue PRO and Pros for CRM. Its Selling PRO software comprises e-commerce, Smart CPQ and Deal des …
  • LBT Innovations Limited (LBT)-医療機器分野：企業M&A・提携分析
    Summary LBT Innovations Limited (LBT) is a medical device company that designs, develops and commercializes various products and automation technologies for the preparation and analysis of microbiology culture specimens, and microbiology and diagnostic laboratory services. It offers MicroStreak tech …
  • Impinj Inc (PI)：企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆